Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 11/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL802630 | 0.87 | MAPT (0.48) | ALDH1A1SMN1; SMN2MAPTROCK2AAK1 | |
| SCHEMBL802742 | 0.84 | KMT2A (0.41) | AKR1B1MAPTMAOAMAOB | |
| SCHEMBL15292004 | 0.83 | MAPT (0.44) | ALDH1A1SMN1; SMN2MAPTROCK2AAK1 | |
| SCHEMBL22600498 | 0.77 | ELANE (0.40) | MAOAMAOB | |
| SCHEMBL75194 | 0.76 | MAPT (0.49) | ALDH1A1SMN1; SMN2MAPTMAOAMAOB | |
| SCHEMBL16487799 | 0.76 | PTGS1 (0.48) | SMN1; SMN2MAPTMAOA | |
| SCHEMBL18365493 | 0.74 | MAPT (0.60) | ALDH1A1SMN1; SMN2MAPTMAOAMAOB | |
| SCHEMBL783519 | 0.73 | KMT2A (0.51) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL2604680 | 0.73 | KMT2A (0.48) | ALDH1A1SMN1; SMN2MAPTMAOA | |
| SCHEMBL14048480 | 0.72 | ELANE (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | LPXN, VCL, ACP3 | AKR1B1 3961/4885ALDH1A1 3543/4885SMN1; SMN2 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.